ArticleAmerican journal of nuclear medicine and molecular imaging2015

Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.

David E Gerber et al.PubMed ↗Full text ↗

No numbers read from the abstract.